A new type of natural bispecific antibody with potential protective effect in hashimoto thyroiditis

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 9, 2014, Pages E1602-E1609

  Li, Wenli ^a,b   Fan, Gaowei ^a,b   Chen, Lida ^a,b   Zhang, Rui ^a   Zhang, Kuo ^a   Sun, Yu ^a   Lin, Guigao ^a   Xie, Jiehong ^a   Wang, Lunan ^a   Li, Jinming ^a  

^a National Centre of Gerontology   (China)

^b GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; BISPECIFIC ANTIBODY; C REACTIVE PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN G4; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; AUTOANTIBODY; IMMUNOGLOBULIN G; IODIDE PEROXIDASE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY COMBINING SITE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HASHIMOTO DISEASE; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; SEROPREVALENCE; YOUNG ADULT; ANTIBODY SPECIFICITY; BINDING COMPETITION; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; IMMUNOLOGY; IMMUNOTHERAPY; ISOLATION AND PURIFICATION; PROCEDURES;

ADULT; AGED; ANTIBODIES, BISPECIFIC; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BINDING, COMPETITIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HASHIMOTO DISEASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOTHERAPY; IODIDE PEROXIDASE; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; THYROGLOBULIN; YOUNG ADULT;

EID: 84907188818     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4108     Document Type: Article

References (30)

1. Edelman GM, Cunningham BA, Gall WE, Gottlieb PD, Rutishauser U, Waxdal MJ. The covalent structure of an entire -G immunoglobulin molecule. Proc Natl Acad Sci USA. 1969;63: 78-85.
2. Schuurman J, Van Ree R, Perdok GJ, Van Doorn HR, Tan KY, Aalberse RC. Normal human immunoglobulin G4 is bispecific: It has two different antigen-combining sites. Immunology. 1999;97: 693-698.
3. van der Neut KM, Schuurman J, Losen M, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science. 2007;317: 1554-1557.
4. Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: An odd antibody. Clin Exp Allergy. 2009;39: 469-477.
5. Rispens T, Ooijevaar-de HP, Bende O, Aalberse RC. Mechanism of immunoglobulin G4 Fab-arm exchange. JAmChem Soc. 2011;133: 10302-10311.
6. Wang W, Xu R, Li J. Production of native bispecific antibodies in rabbits. PLoS One. 2010;5: 10879.
7. Wang W, Li J. Identification of natural bispecific antibodies against cyclic citrullinated peptide and immunoglobulin G in rheumatoid arthritis. PLoS One. 2011;6: 16527.
8. Xie LD, Gao Y, Li MR, Lu GZ, Guo XH. Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashimoto's thyroiditis with different thyroid functional status. Clin Exp Immunol. 2008;154: 172-176.
9. Czarnocka B. Thyroperoxidase, thyroglobulin, Na(-)/I(-) symporter, pendrin in thyroid autoimmunity. Front Biosci (Landmark Ed). 2011;16: 783-802.
10. Li Y, Nishihara E, Kakudo K. Hashimoto's thyroiditis: Old concepts and new insights. Curr Opin Rheumatol. 2011;23: 102-107.
11. Li Y, Zhou G, Ozaki T, et al. Distinct histopathological features of Hashimoto's thyroiditis with respect to IgG4-related disease. Mod Pathol. 2012;25: 1086-1097.
12. Kakudo K, Li Y, Taniguchi E, et al. IgG4-related disease of the thyroid glands. Endocr J. 2012;59: 273-281.
13. Stone JH, Zen Y, Deshpande V. IgG4-related disease.NEngl J Med. 2012;366: 539-551.
14. Avrameas S, Ternynck T. Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration. Immunochemistry. 1971;8: 1175-1179.
15. Crowther JR. TheELISAGuide Book. Totowa, NJ: Humana; 1995: 83-113.
16. Boekholdt SM, Titan SM, Wiersinga WM, et al. Initial thyroid status and cardiovascular risk factors: The EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf). 2010;72: 404-410.
17. Silva LM, Chavez J, Canalli MH, Zanetti CR. Determination of IgG subclasses and avidity of antithyroid peroxidase antibodies in patients with subclinical hypothyroidism-A comparison with patients with overt hypothyroidism. Horm Res. 2003;59: 118-124.
18. Zhang Y, Gao Y, Li M, et al. Avidity of thyroglobulin antibody in sera from patients with Hashimoto's thyroiditis with different thyroidfunctional status. Clin Exp Immunol. 2010 Jul 1;161(1): 65-70.
19. Weetman AP. Autoimmune thyroid disease. Autoimmunity. 2004; 37(4): 337-340.
20. Ahmed R, Al-Shaikh S, Akhtar M. Hashimoto thyroiditis: A century later. Adv Anat Pathol. 2012;19: 181-186.
21. Henry M, Zanelli E, Malthiery Y. Anti-human thyroid peroxidase and anti-human thyroglobulin antibodies present no cross-reactivity on recombinant peptides. Clin Exp Immunol. 1991;86: 478-482.
22. Davies AM, Rispens T, den Bleker TH, et al. Crystal structure of the human IgG4 C(H)3 dimer reveals the role of Arg409 in the mechanism of Fab-arm exchange. Mol Immunol. 2012;54: 1-7.
23. Sedykh SE, Buneva VN, Nevinsky GA. Human milk IgGs contain various combinations of different antigen-binding sites resulting in multiple variants of their bispecificity. PLoS One. 2012;7: E42942.
24. Kojima M, Hirokawa M, Kuma H, et al. Distribution of IgG4- and/or IgG-positive plasma cells in Hashimoto's thyroiditis: An immunohistochemical study. Pathobiology. 2010;77: 267-272.
25. Deshpande V, Huck A, Ooi E, Stone JH, Faquin WC, Nielsen GP. Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease. J Clin Pathol. 2012;65: 725-728.
26. Kawashima ST, Tagami T, Nakao K, et al. Serum levels of IgG and IgG4 in Hashimoto thyroiditis. Endocrine. 2014;45(2): 236-243.
27. Li Y, Nishihara E, Hirokawa M, Taniguchi E, Miyauchi A, Kakudo K. Distinct clinical, serological, and sonographic characteristics of Hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab. 2010;95: 1309-1317.
28. Du Clos TW. C-reactive protein as a regulator of autoimmunity and inflammation. Arthritis Rheum. 2003;48: 1475-1477.
29. Jensen LE, Whitehead AS. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J. 1998;334: 489-503.
30. Ganesh BB, Bhattacharya P, Gopisetty A, Prabhakar BS. Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J Interferon Cytokine Res. 2011;31: 721-731.